サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1795278

粘液除去装置の世界市場

Mucus Clearance Devices

出版日
ページ情報
英文 175 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.92円
粘液除去装置の世界市場
出版日: 2025年08月21日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 175 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

粘液除去装置の世界市場は2030年までに7億3,420万米ドルに達する見込み

2024年に5億5,780万米ドルと推定される粘液除去装置の世界市場は、2030年には7億3,420万米ドルに達し、分析期間2024-2030年のCAGRは4.7%で成長すると予測されます。本レポートで分析したセグメントの1つであるCOPD &Asthma Indicationは、CAGR 5.5%を記録し、分析期間終了時には4億9,300万米ドルに達すると予測されます。嚢胞性線維症（Cystic Fibrosis）適応症分野の成長率は、分析期間中CAGR 3.0%と推定されます。

米国市場は1億5,200万米ドルと推定、中国はCAGR8.7%で成長すると予測

米国の粘液除去装置市場は、2024年に1億5,200万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 8.7%で推移し、2030年には1億5,420万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.9%と3.7%と予測されています。欧州では、ドイツがCAGR 2.8%で成長すると予測されています。

世界の粘液除去装置市場- 主要動向と促進要因のまとめ

なぜ粘液除去装置はより広範な臨床応用を獲得しているのか？

粘液除去装置は、粘液貯留を特徴とする呼吸器疾患の管理において、ますます重要性を増しています。これらのデバイスは、患者が粘液をより効果的に排出し、感染症のリスクを低減し、肺機能を改善することで、気道衛生をサポートします。慢性閉塞性肺疾患、嚢胞性線維症、気管支拡張症、神経筋障害の治療に広く使用されています。呼吸器疾患は、高齢化社会においても、公害や職業上の危険にさらされている人々においても増加傾向にあり、粘液除去装置の臨床使用は着実に増加しています。

デバイスは、単純な機械的振動ツールから、呼気陽圧や高周波胸壁振動を使用したより高度なシステムまで多岐にわたる。患者は、薬物療法だけに頼ることなく粘液動員を改善することにより、これらのシステムから利益を得ることができます。病院の呼吸ケアチームは、特に咳の強さが低下している患者や気道クリアランスが低下している患者に対して、長期的な呼吸療法にこれらの装置を推奨するようになってきています。使いやすさと、病院内と自宅の両方の環境に適していることが、この機器の普及を後押ししています。

機器の技術革新は気道確保療法をどのように改善しているか？

機器工学の進歩により、粘液クリアランスシステムの有効性、携帯性、使用感が向上しています。多くの新しいモデルは、コンパクトで軽量であり、独立して使用できるように設計されています。その中には、外部電源なしで使用できる手持ち式の振動式呼気陽圧装置もあり、旅行や在宅ケアに適しています。気道の振動と圧力の調節を組み合わせた装置もあり、粘液をより効果的に排出する2つのメカニズムが提供されています。

デジタルモニタリング機能も導入され、臨床医が治療のアドヒアランスや患者のパフォーマンスをリアルタイムで追跡できるようになっています。呼気流量、抵抗レベル、使用頻度に関するフィードバックを提供する機器は、治療計画の個別化に役立っています。モバイル・アプリケーションとの統合は、遠隔地からの患者参加とデータ共有をサポートします。進行性の神経筋障害を持つ患者には、プログラム可能な圧力設定を持つ高周波胸壁振動ベストが、受動的クリアランスのためのオーダーメイドのサポートを提供し、快適性と臨床転帰を改善します。

市場拡大を牽引するエンドユースセグメントは？

急性期医療と慢性期医療の両方で採用が増加しています。病院や専門クリニックでは、術後の回復期、集中治療患者、挿管や鎮静のために気道確保が低下している患者などにこれらの機器を使用しています。慢性期医療では、粘液が頻繁に蓄積し、クリアランスが損なわれる呼吸器疾患を管理する患者が長期的に使用されます。肺リハビリテーションセンターや在宅ヘルスケアプロバイダーも重要な成長セグメントです。

小児用は、特に嚢胞性線維症の管理で注目されています。小児用に設計された装置は、使いやすさ、治療時間の短さ、調節可能な圧力設定に重点が置かれています。在宅環境では、介護者や患者は、セットアップが最小限で済み、洗浄が簡単で、使用方法が明確に説明されているシステムを好みます。保険適用と医師の処方ガイドラインは、公的医療環境と民間医療環境の両方での導入に強く影響し、特に包括的な呼吸療法計画に機器が組み込まれている場合に顕著です。

粘液除去装置市場の成長はいくつかの要因によって牽引...

粘液除去装置市場の成長はいくつかの要因によって牽引されます。慢性呼吸器疾患の世界の罹患率の上昇により、気道衛生ソリューションのニーズが高まっています。ポータブルでユーザーフレンドリーな設計の技術的向上が、家庭での幅広い普及を支えます。デジタル機能と接続デバイスの拡大により、リアルタイムの追跡と治療の最適化が可能に。神経筋疾患や閉塞性肺疾患の診断率の向上により、一貫した機器需要が生まれます。呼吸ケアにおける非薬理学的治療アプローチの重視も普及を後押ししています。最後に、病院サプライチェーン、小売薬局、在宅ケアプロバイダーを通じて入手できるようになったことで、多様な患者グループへのアクセスが強化されています。

セグメント

適応症（COPDおよび喘息適応症、嚢胞性線維症適応症、その他の適応症）

調査対象企業の例

  • Abbott（Hill-Rom）
  • Agilent Technologies
  • Allergan（AbbVie）
  • Apex Medical（Wellell）
  • Boehringer Laboratories
  • Dymedso Inc.
  • Electromed, Inc.
  • Fisher & Paykel Healthcare
  • General Physiotherapy, Inc.
  • Hans Rudolph, Inc.
  • Hill-Rom Holdings（Baxter）
  • Med Systems, Inc.
  • Medtronic
  • Monaghan Medical Corporation
  • Olympus Corporation
  • PARI GmbH
  • Philips Respironics（Philips）
  • Smiths Medical
  • Thayer Medical
  • VORTRAN Medical Technology 1 Inc.

AI統合

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP37450

Global Mucus Clearance Devices Market to Reach US$734.2 Million by 2030

The global market for Mucus Clearance Devices estimated at US$557.8 Million in the year 2024, is expected to reach US$734.2 Million by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. COPD & Asthma Indication, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$493.0 Million by the end of the analysis period. Growth in the Cystic Fibrosis Indication segment is estimated at 3.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$152.0 Million While China is Forecast to Grow at 8.7% CAGR

The Mucus Clearance Devices market in the U.S. is estimated at US$152.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$154.2 Million by the year 2030 trailing a CAGR of 8.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Mucus Clearance Devices Market - Key Trends & Drivers Summarized

Why Are Mucus Clearance Devices Gaining Broader Clinical Adoption?

Mucus clearance devices are becoming increasingly important in the management of respiratory conditions characterized by mucus retention. These devices support airway hygiene by helping patients expel mucus more effectively, reducing the risk of infections and improving lung function. They are widely used in the treatment of chronic obstructive pulmonary disease, cystic fibrosis, bronchiectasis, and neuromuscular disorders. With respiratory diseases on the rise, both in aging populations and among individuals exposed to pollution or occupational hazards, clinical use of mucus clearance devices is growing steadily.

Devices range from simple mechanical oscillatory tools to more advanced systems that use positive expiratory pressure or high-frequency chest wall oscillation. Patients benefit from these systems by improving mucus mobilization without relying solely on medication. Hospital-based respiratory care teams increasingly recommend these devices for long-term respiratory therapy, especially for individuals with reduced cough strength or compromised airway clearance. Ease of use and suitability for both in-hospital and home settings further contribute to their rising adoption.

How Are Device Innovations Improving Airway Clearance Therapy?

Advancements in device engineering are enhancing the effectiveness, portability, and user experience of mucus clearance systems. Many newer models are compact, lightweight, and designed for independent use. These include hand-held oscillatory positive expiratory pressure devices that can be used without external power, making them suitable for travel and home-based care. Some devices combine airway vibration with pressure modulation, offering dual mechanisms to dislodge mucus more effectively.

Digital monitoring capabilities are also being introduced, allowing clinicians to track therapy adherence and patient performance in real time. Devices that provide feedback on expiratory flow, resistance levels, and usage frequency are helping personalize therapy plans. Integration with mobile applications supports remote patient engagement and data sharing. For individuals with progressive neuromuscular disorders, high-frequency chest wall oscillation vests with programmable pressure settings offer tailored support for passive clearance, improving comfort and clinical outcomes.

Which End-Use Segments Are Driving Market Expansion?

Adoption is increasing in both acute and chronic care environments. Hospitals and specialty clinics use these devices for post-operative recovery, intensive care patients, and individuals with reduced airway clearance due to intubation or sedation. In chronic care, long-term users include those managing respiratory conditions that involve frequent mucus buildup and impaired clearance. Pulmonary rehabilitation centers and home healthcare providers also represent important growth segments.

Pediatric use is gaining attention, particularly for cystic fibrosis management. Devices designed for children focus on ease of use, shorter therapy durations, and adjustable pressure settings. In home settings, caregivers and patients prefer systems that require minimal setup, are easy to clean, and include clear usage instructions. Insurance coverage and physician prescription guidelines strongly influence adoption in both public and private healthcare settings, especially where devices are integrated into comprehensive respiratory therapy plans.

Growth in the Mucus Clearance Devices Market Is Driven by Several Factors…

Growth in the mucus clearance devices market is driven by several factors. Rising global incidence of chronic respiratory diseases increases the need for airway hygiene solutions. Technological improvements in portable and user-friendly designs support wider home-based adoption. Expansion of digital features and connected devices enables real-time tracking and therapy optimization. Higher diagnosis rates for neuromuscular and obstructive lung conditions generate consistent device demand. Greater emphasis on non-pharmacological treatment approaches in respiratory care also supports adoption. Finally, increased availability through hospital supply chains, retail pharmacies, and homecare providers strengthens access across diverse patient groups.

SCOPE OF STUDY:

The report analyzes the Mucus Clearance Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Indication (COPD & Asthma Indication, Cystic Fibrosis Indication, Other Indications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbott (Hill-Rom)
  • Agilent Technologies
  • Allergan (AbbVie)
  • Apex Medical (Wellell)
  • Boehringer Laboratories
  • Dymedso Inc.
  • Electromed, Inc.
  • Fisher & Paykel Healthcare
  • General Physiotherapy, Inc.
  • Hans Rudolph, Inc.
  • Hill-Rom Holdings (Baxter)
  • Med Systems, Inc.
  • Medtronic
  • Monaghan Medical Corporation
  • Olympus Corporation
  • PARI GmbH
  • Philips Respironics (Philips)
  • Smiths Medical
  • Thayer Medical
  • VORTRAN Medical Technology 1 Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Mucus Clearance Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Respiratory Diseases Drives Demand for Effective Mucus Clearance Solutions
    • Increased Incidence of COPD, Cystic Fibrosis, and Bronchiectasis Spurs Use of Airway Clearance Devices
    • Growing Preference for Non-Invasive Respiratory Therapy Throws Spotlight on Portable Mucus Clearance Tools
    • Expansion of Home Healthcare and Remote Patient Monitoring Encourages Use of Personal Airway Devices
    • Advancements in Oscillatory Positive Expiratory Pressure (OPEP) and High-Frequency Chest Wall Oscillation (HFCWO) Devices Enhance Patient Compliance
    • Development of Battery-Operated and Compact Models Improves Portability and Daily Usage Convenience
    • Integration of Digital Monitoring and App-Based Feedback Supports Long-Term Treatment Adherence
    • Rising Use in Postoperative Respiratory Care and ICU Recovery Protocols Strengthens Clinical Demand
    • Increased Awareness of Early Intervention in Pediatric Respiratory Conditions Fuels Market Growth
    • Shift Toward Self-Managed Airway Hygiene Supports Direct-to-Consumer Sales and Device Accessibility
    • Regulatory Approvals for New Airway Clearance Technologies Accelerate Market Entry of Advanced Systems
    • Growth in Pulmonary Rehabilitation Programs Enhances Integration of Mucus Clearance Devices in Care Plans
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Mucus Clearance Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Mucus Clearance Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Mucus Clearance Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Mucus Clearance Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for COPD & Asthma Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for COPD & Asthma Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for COPD & Asthma Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cystic Fibrosis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Cystic Fibrosis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Cystic Fibrosis Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Mucus Clearance Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • JAPAN
    • Mucus Clearance Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • CHINA
    • Mucus Clearance Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: China 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • EUROPE
    • Mucus Clearance Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Mucus Clearance Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Mucus Clearance Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Mucus Clearance Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • FRANCE
    • Mucus Clearance Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: France 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • GERMANY
    • Mucus Clearance Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Mucus Clearance Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Mucus Clearance Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Mucus Clearance Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Mucus Clearance Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Mucus Clearance Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Mucus Clearance Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • INDIA
    • Mucus Clearance Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: India 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Mucus Clearance Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Mucus Clearance Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Mucus Clearance Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Mucus Clearance Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Mucus Clearance Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Mucus Clearance Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Mucus Clearance Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Mucus Clearance Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030
  • AFRICA
    • Mucus Clearance Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Mucus Clearance Devices by Indication - COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Mucus Clearance Devices by Indication - Percentage Breakdown of Value Sales for COPD & Asthma Indication, Cystic Fibrosis Indication and Other Indications for the Years 2014, 2025 & 2030

IV. COMPETITION